We are a specialist broking company that operates exclusively in the world of litigation finance and insurance, accessing over $5 billion of capital from over 30 funding and insurance companies, including exclusive insurance markets and capital sources.
We have been at the forefront of this highly specialist industry for nearly two decades, with a well-established reputation as the market leader.
We streamline and simplify the process by providing law firms and their clients with competitive choice and cutting edge advice. We are routinely engaged by claimants seeking third party funding, litigation insurance and risk management and/or operating capital during the life of the legal proceedings, or seeking to enforce or sell judgements or arbitral awards.
In addition, we also work with corporate enterprises involved in M&A transactions who require off balance sheet solutions for potentially obstructive litigation-related liabilities.
Unlike many brokers, we do not charge any fees for our services, nor is our commission added to the cost of the funding or insurance arrangement. We exist to get our clients from enquiry to completed funding arrangement as quickly and painlessly as possible, whilst saving our clients’ money on chargeable law firm time in liaising with insurers and funders.
Let us understand your particular circumstances and objectives and we can deliver the right solution tailored to your requirements.
Contact us to learn more.
More Capital = More Deployment Pressure & Off Piste Investing
thejudge • March 16th, 2017
Recent reports in the press have highlighted the significant amount of growth in litigation funding capital there has been in the last two years. A study by RPC identified an increase of 55% in the amount capital available to deploy … Continued
Litigation Funding; No Rush to Regulate
thejudge • March 15th, 2017
In response to a series of questions regarding the regulation of the litigation funding industry, the Government conclude a present lack of need for further assessment. Despite its proliferation over the past decade, the market for litigation funding remains largely … Continued
Do funders really understand their exposure to Arkin risk after the COA decision in Excalibur?
thejudge • December 20th, 2016
On 18th November the Court of Appeal handed down their much anticipated judgment in Excalibur. The case itself has become the example for participants within the industry to demonstrate how not to approach litigation funding as well as the glaring … Continued